Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Acute Pancreatitis I: Introduction01:25

Acute Pancreatitis I: Introduction

Acute pancreatitis is the sudden inflammation of the pancreas caused by the early activation of digestive enzymes, leading to the autodigestion of pancreatic tissue. This results in local inflammation and, in severe cases, systemic complications.EtiologyUnderstanding the underlying causes is crucial, as identifying the etiology guides treatment and anticipates complications. Acute pancreatitis can be triggered by various factors, typically grouped into the following clinical categories.Biliary...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of Two Different Doses of Ampicillin-Sulbactam as Part of Combination Therapy in the Treatment of Multidrug Resistant <i>Acinetobacter baumannii</i> Ventilator Associated Pneumonia: A Randomized Clinical Trial.

Infection and drug resistance·2026
Same author

Disseminated Infection With <i>Mycobacterium genavense</i> in the Setting of HIV Infection Misdiagnosed as Sarcoidosis.

Case reports in infectious diseases·2025
Same author

Comparison of Pharmacokinetic/Pharmacodynamic Parameters and Clinical Outcomes of Vancomycin Administered in Two Different Dosage Regimens in Patients with Acute Kidney Injury.

Iranian journal of pharmaceutical research : IJPR·2025
Same author

Spinal tuberculosis in Afghanistan: A 2019-2020 study of patients in Kabul hospitals.

Public health challenges·2025
Same author

Bendamustine and pneumocystis pneumonia: A systematic review.

Health science reports·2022
Same author

Clinical and Epidemiological Characteristics of Postdischarge Patients With COVID-19 in Tehran, Iran: Protocol for a Prospective Cohort Study (Tele-COVID-19 Study).

JMIR research protocols·2021

Related Experiment Video

Updated: May 20, 2026

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
10:30

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

Published on: December 27, 2013

5.7K

Chronic Botulism in Humans: A Case Series.

Minoosh Shabani Barzegar1, Sara Pourhemmati2, Masoud Mardani1

  • 1Department of Infectious Disease, School of Medicine Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences Tehran Iran.

Clinical Case Reports
|December 17, 2025
PubMed
Summary

This study details unusual botulism cases in humans and goats from one farm, linked to animal visceral botulism. Persistent weight loss and weakness were key signs, though less severe than typical botulism.

Keywords:
Clostridium botulinumbotulismcase serieshuman botulismneurologic manifestationweight loss

More Related Videos

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
12:25

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

16.5K
A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
14:10

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

Published on: November 14, 2014

8.9K

Related Experiment Videos

Last Updated: May 20, 2026

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
10:30

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

Published on: December 27, 2013

5.7K
Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
12:25

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

16.5K
A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
14:10

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

Published on: November 14, 2014

8.9K

Area of Science:

  • Veterinary Medicine
  • Clinical Neurology
  • Infectious Diseases

Background:

  • Botulism is a rare but serious paralytic illness caused by toxins produced by Clostridium botulinum bacteria.
  • Typical botulism presentations involve descending muscle paralysis, potentially leading to respiratory failure.
  • Animal visceral botulism, particularly in livestock, can serve as a potential source of human infection.

Purpose of the Study:

  • To describe novel clinical manifestations of botulism observed concurrently in humans and goats from a single farm.
  • To investigate the potential link between human botulism cases and animal visceral botulism within the same environment.
  • To characterize the specific symptoms, focusing on atypical presentations and severity.

Main Methods:

  • Clinical case observation and symptom documentation in affected human patients.
  • Veterinary examination and diagnostic assessment of affected goats on the farm.
  • Epidemiological investigation to establish potential transmission links and common sources.

Main Results:

  • Concurrent onset of botulism symptoms in human patients and goats residing on the same farm was documented.
  • Persistent clinical signs included significant weight loss and generalized weakness in both species.
  • The observed symptoms, while characteristic of botulism, were notably less severe and not immediately life-threatening compared to typical presentations.

Conclusions:

  • The findings suggest a potential association between human botulism cases and animal visceral botulism, possibly originating from a shared environmental source.
  • The study highlights atypical, non-life-threatening clinical presentations of botulism, emphasizing the importance of considering milder forms in diagnosis.
  • Further research is warranted to elucidate the specific transmission dynamics and the factors contributing to the observed variations in botulism severity.